These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30734088)

  • 21. Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism.
    Agnelli G; Becattini C
    Hematology Am Soc Hematol Educ Program; 2013; 2013():471-7. PubMed ID: 24319221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.
    Barnes GD; Kanthi Y; Froehlich JB
    Vasc Med; 2015 Apr; 20(2):143-52. PubMed ID: 25832602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study.
    Lai N; Jones AE; Johnson SA; Witt DM
    J Thromb Thrombolysis; 2021 Aug; 52(2):414-418. PubMed ID: 33486650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.
    Xie L; Liu X; Phatak H; Mardekian J; Tan W; Baser O; Ramacciotti E
    Am J Ther; 2016; 23(6):e1744-e1753. PubMed ID: 26214203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of anticoagulation after venous thromboembolism in real world clinical practice.
    Ageno W; Samperiz A; Caballero R; Dentali F; Di Micco P; Prandoni P; Becattini C; Uresandi F; Verhamme P; Monreal M;
    Thromb Res; 2015 Apr; 135(4):666-72. PubMed ID: 25708926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN; Couturaud F
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE.
    Khorana AA; Berger JS; Wells PS; Seheult R; Ashton V; Laliberté F; Crivera C; Lejeune D; Schein J; Wildgoose P; Lefebvre P; Kaatz S
    Clin Ther; 2017 Jul; 39(7):1396-1408. PubMed ID: 28645879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current criteria to determine the duration of anticoagulant therapy].
    Palareti G
    Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
    Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer.
    Dhamane AD; Shah S; Noxon V; Bruette R; Ferri M; Liu X; Jiang J; Luo X
    Thromb Res; 2023 Apr; 224():52-59. PubMed ID: 36848784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.
    Tagalakis V; Patenaude V; Kahn SR; Suissa S
    Thromb Res; 2014 Oct; 134(4):795-802. PubMed ID: 25135794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.
    Reardon G; Pandya N; Nutescu EA; Lamori J; Damaraju CV; Schein J; Bookhart BK
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):361-72. PubMed ID: 23217529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
    Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
    Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 37. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism - still a challenging issue.
    Elmi G; Di Pasquale G; Pesavento R
    Vasa; 2017 Mar; 46(2):87-95. PubMed ID: 28102773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Martín-Martos F; Trujillo-Santos J; Del Toro J; Bura-Riviere A; Lorenzo A; Barillari G; Soler S; Mahè I; Sahuquillo JC; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S16-S20. PubMed ID: 28262228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
    de Jong PG; Coppens M; Middeldorp S
    Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
    Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.